Revitaderm Psoriasis Ointment
Product Images NDC 63347-112

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Revitaderm Psoriasis (NDC 63347-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blaine Labs Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blaine_revitaderm_psoriasis1 (Blaine Revitaderm Psoriasis1)

Label for RevitaDERM PSORIASIS Treatment topical ointment with colloidal silver, 4 fl. oz., by Blaine Labs Inc. The label highlights a proven formula with antimicrobial colloidal silver to address psoriasis symptoms and prevent infection. Directions state to apply as needed up to four times daily. The product NDC is 63347-112-01.*

FDA Label Image

Blaine_revitaderm_psoriasis2 (Blaine Revitaderm Psoriasis2)

RevitaDERM PSORIASIS Treatment ointment with 2% coal tar and colloidal silver, indicated for topical use. The label highlights its use for relieving symptoms of psoriasis, eczema, and seborrheic dermatitis including itching, flaking, and redness. The product is in a 4 fl. oz. container from Blaine Labs Inc., Santa Fe Springs, CA. Packaging emphasizes antimicrobial properties and guarantees temporary relief.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.